A 'distant' bystander effect of suicide gene therapy: Regression of nontransduced tumors together with a distant transduced tumor

Human Gene Therapy

Volumn 8, Issue 15, 1997, Pages 1807-1814

  Kianmanesh, Ali Reza ^a  

^a Paris V University ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; GENE THERAPY; LIVER TUMOR; MACROPHAGE; NONHUMAN; RAT; SUICIDE GENE; T LYMPHOCYTE;

ANIMALIA; HERPES;

EID: 0030668915     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.15-1807     Document Type: Article

References (13)

1. ANDERSON, W. (1992). Human gene therapy. Science 256, 808-813.
2. BARBA, D., HARDIN, J., SADELAIN, M., and GAGE, F.H. (1994). Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA 91, 4348-4352.
3. BI, L.W. PARYSEK, L.M., WARNICK, R., and STAMBROOKS, P.J. (1993). In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum. Gene Ther. 4, 725-731.
4. CARLSSON, G., GULLBERG, B., and HAFSTRÖM, L. (1983). Estimations of liver tumor volume using different formulas - An experimental study in rats. J. Cancer Res. Clin. Oncol. 105, 20-23.
5. CARUSO, M., PANIS, Y., GAGANDEEP, S., HOUSSIN, D., SALZMANN, J.L., and KLATZMANN, D. (1993). Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA 90, 7024-7028.
6. CHEN, S., LI CHEN, X.H., Y., W., KOSAI, K., FINEGOLD, M.J., and RICH, S. (1995). Combinaison gene therapy for liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2577-2581.
7. COLOMBO, B.M., BENEDETTI, S., OTTOLENGHI, S., MORA, M., POLLO, B., POLI, G., and FINOCCHIARO, G. (1995). The "bystander effect": Association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum. Gene Ther. 6, 763-772.
8. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
9. DILBNER, M., MR, A., BJORSTRAND, B., CHRISTENSSON, B., GAHRTON, G., XANTHOPOULOS, K., and SMITH, E. (1996). Suicide gene therapy for plasma cell tumors. Blood 88, 2192-2200.
10. ELION, G. (1983). The biochemistry and mechanism of action of acyclovir. J. Antimicrob. Chemother. 12(Suppl. B), 9-17.
11. ELSHAMI, A.A., SAAVEDRA, A., ZHANG, H., KUCHARCZUK, J.C., SPRAY, D.C., FISHMAN, G.I., AMIN, K.M., LITZKI, L.A., and KAISER, L.R. (1996). Gap junctions play a role in the 'bystander effect' of the herpes simplex virus thymidine kinase/ganciclovir system in vitro. Gene Ther. 3, 85-92.
12. FREEMAN, S.M., RAMESH, R., SHASTRI, M., MUNSHI, A., JENSEN, A.K., and MARROGI, A.J. (1995). The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells. Cancer Lett. 92, 167-174.
13. FREEMAN, S.M., WHARTENBY, K.A., FREEMAN, J.L., ABBOUD, C.N., and MARROGI, A.J. (1996). In situ use of suicide genes for cancer therapy. Semin. Oncol. 23, 31-45.